Location: United Kingdom
Total raised: $94.43M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.11.2025 | Series A | $94.43M | Eli Lilly ... |
Mentions in press and media 8
| Date | Title | Description |
| 06.11.2025 | DIGIT Deal Roundup | October 2025 | Welcome to October 2025’s DIGIT Deal Roundup. Christmas came very early for a raft of Scottish firms last month, with tens of millions in fresh investment targeting Scotland’s medtech stars, robot builders, EV makers, and agri-tech innovato... |
| 13.10.2025 | Trogenix: $95 Million Series A Closed For Advancing Clinical Development Of Curative Cancer Therapies | Trogenix, a biotech company dedicated to developing innovative therapies for cancer treatment, announced the closing of its Series A financing round at £70 million (approximately $95 million). This funding will accelerate the development of... |
| 07.10.2025 | Precision Oncology Pioneer Trogenix Secures Landmark €80M Series A for Curative Cancer Fight | Trogenix, an Edinburgh-based biotech, secured a monumental €80 million Series A funding. This capital empowers its pursuit of curative cancer treatments for aggressive solid tumors. The firm's Odysseus platform uses advanced gene control an... |
| 06.10.2025 | Edin Uni Spinout Trogenix Raises £70M to Treat Aggressive Cancers | University of Edinburgh spinout Trogenix, which is developing curative therapies for aggressive, treatment-resistant cancers, has completed Series A financing of £70 million. The funding will allow the biotech company to rapidly advance its... |
| 06.10.2025 | Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments | Trogenix Ltd, a Scottish BioTech company dedicated to innovative cancer therapies, announced the completion of its Series A financing, raising €80 million, to advance its pipeline of potentially curative cancer therapies across multiple agg... |
| 06.10.2025 | Calculus invests in Trogenix | - |
| 06.10.2025 | Trogenix Raises £70M in Series A Financing | Trogenix, an Edinburgh, Scotland, UK-based biotech company founded by 4BIO and dedicated to developing new cancer therapies, raised £70M in Series A funding. The round was led by IQ Capital with participation from new investors Eli Lilly an... |
| - | Trogenix | “Home - Trogenix” |